Merck vs Teva Pharmaceutical Industries
Merck (MRK) and Teva Pharmaceutical Industries (TEVA) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $330B
- Last close
- $133.72
- 12 months
- +40.8%
- Market value
- $45.8B
- Last close
- $39.23
- 12 months
- +61.6%
At a glance
- The biggest part of Merck's revenue is Pharmaceutical (89%); at Teva Pharmaceutical Industries it is Sale of Goods (85%).
- By market value, Merck ($329.7B) is about 7.2 times Teva Pharmaceutical Industries ($45.8B).
- Over the last 12 months Merck's share price moved +40.8% and Teva Pharmaceutical Industries's +61.6%; against the S&P 500 that is +35.1 points and +55.9 points.
- In their last fiscal years Merck kept 28.1% of revenue as net income and Teva Pharmaceutical Industries 8.2%.
- In the last 90 days insiders reported 0 open-market purchases at Merck and 0 at Teva Pharmaceutical Industries; members of Congress disclosed 3 trades in Merck and 0 in Teva Pharmaceutical Industries.
- Next results: Merck Feb 2, 2027, Teva Pharmaceutical Industries not announced.
How each one makes money: Merck revenue · Teva Pharmaceutical Industries revenue
Share prices on one chart
Merck and Teva Pharmaceutical Industries, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Merck MRKNYSE · Pharmaceuticals | Teva Pharmaceutical Industries TEVANYSE · Pharmaceutical Preparations | |
|---|---|---|
| Size and profitability | ||
| Market value | $330B | $45.8B |
| Revenue, last fiscal year | $65B | $17.3B |
| Net income, last fiscal year | $18.3B | $1.41B |
| Net marginNet income as a share of revenue | 28.1% | 8.2% |
| Free cash flow | $12.4B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Merck against
Common questions
How is Merck different from Teva Pharmaceutical Industries?
Merck (MRK) is in Pharmaceuticals on NYSE, with $65B of revenue in its last fiscal year and a net margin of 28.1%. Teva Pharmaceutical Industries (TEVA) is in Pharmaceutical Preparations on NYSE, with $17.3B of revenue in its last fiscal year and a net margin of 8.2%. The biggest part of Merck's revenue is Pharmaceutical (89%); at Teva Pharmaceutical Industries it is Sale of Goods (85%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Merck and Teva Pharmaceutical Industries compare in size?
Merck has the larger market value: Merck $330B and Teva Pharmaceutical Industries $45.8B, at the last close.
Whose share price rose more over the last 12 months, MRK or TEVA?
Over the last 12 months Merck moved +40.8% and Teva Pharmaceutical Industries +61.6%. Past price moves say nothing about the future.
Which has had more insider buying, Merck or Teva Pharmaceutical Industries?
Since 2006, Merck insiders reported 30 open-market purchases against 6 for Teva Pharmaceutical Industries. These are counts of what was filed, not a view on either stock.
Do members of Congress trade MRK or TEVA?
In the last 12 months, members of Congress disclosed 9 trades in Merck (MRK) and 0 in Teva Pharmaceutical Industries (TEVA).
When did insiders last buy MRK and TEVA?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Merck pageTeva Pharmaceutical Industries pageRare insider trades this weekAll comparisons
https://oqro.io/compare/mrk-vs-teva







